Malaria vaccine hailed as potential breakthrough

By | April 23, 2021

In a pre-print study with The Lancet, the research team – from Oxford, Nanoro in Burkina Faso and the US – reported the trial results of R21/Matrix-M, after testing a low and high dose of the vaccine in children, between May and August, before peak malaria season.

BBC News – Health

Read More:  What to know about Biden's proposed COVID-19 vaccine patent waivers